 |
| About Bioline | All Journals | Testimonials | Membership | News |
|
||||||
|
||||||
Indian Journal of Dermatology, Venereology and Leprology, Vol. 72, No. 1, January-February, 2006, pp. 59-60 Letter To Editor Stria distensae: Response by authors Singh Gurcharan, Kumar Lekshmi P Department of Dermatology and STD, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka, India Correspondence Address:Dr. Gurcharan Singh, 108 A, Jal Vayu Vihar, Kammanahalli, Bangalore 560043, Karnataka, India. E-mail: gurcharan@vsnl.com Code Number: dv06016 Sir, We thank Dr. Tehrani for his interest and valuable comments in response to our article on "Striae distensae."[1] We have the following observations to make on the current status of microdermabrasion in evidence-based dermatology. Microdermabrasion devices have been classified as cosmetic rather than medical ones and are therefore not subjected to the rigors of the US FDA. Despite the claims and marketing hype, little evidence of efficacy has been provided by double-blinded, clinical trials.[2] No phase-III clinical trials of microdermabrasion devices have ever been conducted to establish their safety and efficacy as required for FDA approval.[3] There remains a major disparity between the popularity and cohesive and comprehensive scientific data documenting the efficacy of the procedure.[4] Moreover, a review article on microdermabrasion does not include striae among an exhaustive list of dermatological indications.[5] References
Copyright 2006 - Indian Journal of Dermatology, Venereology and Leprology |
| |||||||||
